SeaStar Medical Holding Corporation (NasdaqCM: ICU)
Health Care · Health Care Equipment & Supplies · US
$3.18
-5.07% today · -58.1% 1Y
SeaStar Medical Holding Corporation (NasdaqCM: ICU) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $14.76M and employs 17 people.
Over the last twelve months the share price has lost 58.1%, trading between 2.07 and 12.50.
Tweenvest scores SeaStar Medical Holding Corporation across four factors: quality 29/100, value 58/100. Its strongest factor is value.
ICU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.76M
- Revenue (TTM)
- $1.71M
- P/E
- —
- EPS
- -3.81
- Dividend yield
- —
- Beta (5Y)
- -1.04
- 52-week high
- $12.50
- 52-week low
- $2.07
- Avg volume (3M)
- —
- Shares outstanding
- 4.41M
- Employees
- 17
- Next earnings
- —
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome. The firm maintains its headquarters in Denver, Colorado.
- ISIN
- US81256L3024
- Founded
- 2007
- Listed since
- Mar 18, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.00 | -0.11% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $372.64 | +0.22% |
| Stryker CorporationNYSE: SYK | $126.81B | $331.82 | +0.37% |
| Medtronic plcNYSE: MDT | $116.66B | $91.10 | -0.04% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.15 | +0.63% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $48.05 | -3.63% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.